| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | For oral administration |
|
Still deciding? Get samples of US$ 0/Box
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Indications:
Rifampicin Capsule is indicated for the treatment of pulmonary tuberculosis and for the treatment of asymptomatic carriers of N. meningitidis to eliminate meningococci from the nasopharynx.
Contra-indications:
A history of previous hypersensitivity reaction to any of the rifamycins.
Adverse Effects:
Rifampicin Capsule may cause upset stomach, heartburn, nausea, menstrual changes, headache, drowsiness, or dizziness.
Drug Interactions:
Rifampicin Capsule should not be used with the following medications because very serious interactions may occur: live bacterial vaccines (e.g., oral typhoid), certain non-nucleoside reverse transcriptase inhibitors (nevirapine, delavirdine, etravirine), voriconazole, HIV protease inhibitors (e.g., saquinavir, ritonavir, indinavir).
Storage instructions:
Store below 25ºC. Protect from moisture. Keep out of reach of children.
| Testing terms | Standards | Results |
| Characteristics | 0# red capsules | Complies |
| Identification | Should positive reaction | Positive |
| Dissolution | Meet the requirement | Complies |
| Uniformity of content | ≤±7.5% | Complies |
| Microbial contamination | Meet the specification | Complies |
| Assay | 92.5%-107.5% | 98.8% |
){kind=link}